US FDA
-
US FDA flags glaring lapses by Indian firm that made eye drops linked to vision loss and deaths
Tabassum Barnagarwala
-
Covid: Pfizer says its antiviral pill cuts risk of hospitalisation, death by 89%
Scroll Staff
-
Covid-19: Pfizer says its vaccine works for children aged 5 to 11, company to seek US approval soon
Scroll Staff
-
Coronavirus: US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin
Scroll Staff
-
Coronavirus: Pfizer’s vaccine provides strong protection after first dose, says US drug regulator
Scroll Staff
-
US drug agency grants emergency use authorisation to antibody therapy given to Donald Trump
Scroll Staff
-
Coronavirus: US approves first self-testing kit, results at home within 30 minutes
Scroll Staff
-
Covid-19: US FDA withdraws emergency use authorisation for hydroxychloroquine, chloroquine
Scroll Staff
-
Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element
Scroll Staff
-
Indian pharmaceutical firm recalls drug from US after investigation into cancer-causing element
Scroll Staff
-
India’s largest drugmaker gets a warning letter from US FDA
Scroll Staff